spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Healthcare News Roundup: Biopharmaceutical

 HSMN NewsFeed - 12 Feb 2014
Dan Mitchell Joins ARCA biopharma Board of Directors
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 11 Feb 2014
Arvinas Hires Jim Winkler as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Feb 2014
Zocere Appoints Zavitz as Chief Scientific Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 11 Feb 2014
Mallinckrodt plc to Acquire Cadence Pharmaceuticals, Inc. for $14.00 Per Share, in Cash
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Feb 2014
Lithera Announces Final Closing of $35.6 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Feb 2014
Tokai Pharmaceuticals Appoints John McBride as Chief Operating Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 11 Feb 2014
Innovus Pharma Expands Management Team and Adds Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Feb 2014
Mast Therapeutics Signs Definitive Agreement To Acquire Aires Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 Feb 2014
Two-Year Results From Phase 3 VISTA Trial of EYLEA(R) (aflibercept) Injection for the Treatment of Diabetic Macular Edema Show Sustained Improvement in Vision
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 10 Feb 2014
Sunesis Appoints Joseph I. DePinto as Chief Commercial Officer, Updates VALOR Timeline to Unblinding of Data
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 Feb 2014
SciClone Appoints Charles Meng as General Counsel and Vice President of Compliance
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Feb 2014
Covis Pharmaceuticals Announces Its New Expanded Dosage Options of LANOXIN(R) for Cardiac Patients With Mild-to-Moderate Heart Failure
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 7 Feb 2014
Ipsen announces positive top line results from phase III clinical study of Decapeptyl(R) (triptorelin pamoate) 11.25 mg administered subcutaneously in patients with prostate cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Feb 2014
Ultragenyx Appoints Clay Siegall, Ph.D. and Matthew Fust to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Feb 2014
Spectrum Pharmaceuticals Announces FDA’s Acceptance of NDA Filing for Beleodaq(TM) (belinostat) for Injection, a novel pan-HDAC inhibitor
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Feb 2014
Ambrx Appoints Barry Greene to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Feb 2014
aTyr Pharma Appoints Frederic Chereau as President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Feb 2014
Tiltan Pharma Raises $1.5 Million
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 5 Feb 2014
Pernix Attracts $65 Million Institutional Investment; Appoints Doug Drysdale as CEO; Settles Pending Legal Liabilities
Biopharmaceuticals Personnel Litigation
 HSMN NewsFeed - 5 Feb 2014
Ichor Enters into an Agreement with Pfizer to Develop Electroporation Devices for Use in Therapeutic Cancer Vaccine Regimens
Biopharmaceuticals Drug Delivery Oncology Licensing
 HSMN NewsFeed - 5 Feb 2014
Questcor Pharmaceuticals Expands Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Feb 2014
Ipsen announces clinical results of Dysport(R) Next Generation (DNG) and its intent to file the first ready-to-use liquid toxin A in Europe and ROW(1)
Biopharmaceuticals
 HSMN NewsFeed - 4 Feb 2014
BOTOX(R) (Botulinum toxin type A) Receives Approval in the UK for the Treatment of Ankle Disability due to Lower Limb Spasticity Associated with Stroke in Adults
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 4 Feb 2014
Regulus Strengthens Executive Management Team with Addition of David Szekeres as Chief Business Officer and General Counsel
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Feb 2014
Chiesi Farmaceutici Completes Acquisition of Cornerstone Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 4 Feb 2014
Amarin Announces Promotion of Aaron Berg to Senior Vice President, Marketing and Sales
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Feb 2014
Merck Announces Canadian Approval of GRASTEK(R) (Standardized Allergenic Extract, Timothy Grass (Phleum pratense) Sublingual Tablet)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 3 Feb 2014
Valeant Pharmaceuticals to Acquire Precision Dermatology for $475 Million
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 3 Feb 2014
PDL BioPharma Announces Agreement with Genentech and Roche to Settle Litigation and Arbitration
Biopharmaceuticals Litigation
 HSMN NewsFeed - 3 Feb 2014
Mylan Launches First Trastuzumab Biosimilar, Hertraz(TM), in India
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 2 Feb 2014
Forest Laboratories, Inc. Files Lawsuit Against Several Companies for Infringement of NAMENDA XR(R) Patents
Biopharmaceuticals Neurology Generics Litigation
 HSMN NewsFeed - 31 Jan 2014
Eli Lilly and Company Provides Statement in Response to Sanofi U.S. Lawsuit
Biopharmaceuticals Endocrinology Litigation
 HSMN NewsFeed - 31 Jan 2014
Acella Pharmaceuticals, LLC, Announces Approval and Launch of Loutrex Topical Cream
Biopharmaceuticals Devices Dermatology FDA
 HSMN NewsFeed - 31 Jan 2014
Valeant Pharmaceuticals Announces Approval of Retin-A Micro(R) Microsphere 0.08%
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 31 Jan 2014
Actavis Announces Refocused Global Business Structure to Maximize Evolution into Global Specialty Pharmaceuticals Leadership
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jan 2014
ImmunoGen, Inc. Appoints Eric Guempel as Vice President of Product Strategy and Program Management
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 31 Jan 2014
Mylan Named as Gilead's Exclusive Branded Medicines Business Partner for India
Biopharmaceuticals Distribution
 HSMN NewsFeed - 30 Jan 2014
Novo Nordisk Promotes Eddie Williams to Senior Vice President
Biopharmaceuticals Endocrinology Personnel
 HSMN NewsFeed - 30 Jan 2014
Stem Cell Therapeutics Announces Appointment of Dr. Calvin R. Stiller as Chairman
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Jan 2014
Chelsea Therapeutics Names Keith W. Schmidt Chief Commercial Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 30 Jan 2014
Biogen Idec and UCB Enter Agreements to Commercialize Multiple Sclerosis and Hemophilia Therapies in Asia
Biopharmaceuticals Licensing
 HSMN NewsFeed - 29 Jan 2014
Progenics Pharmaceuticals Announces the Appointment of Karen Ferrante, M.D. to Its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 29 Jan 2014
XenoPort Appoints Richard Kim, M.D., as Chief Medical Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 28 Jan 2014
Teva Announces U.S. FDA Approval of Three-Times-a-Week COPAXONE(R) (glatiramer acetate injection) 40mg/mL
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 28 Jan 2014
Veteran Biotech Executive David Arkowitz Joins Spring Bank Pharmaceuticals' Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jan 2014
Igenica Raises $14 Million in Additional Series C Funding to Advance Product Pipeline and Technology Platform
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 27 Jan 2014
Biothera Names VP of Biomarker Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 27 Jan 2014
Purdue Pharma L.P. Names Mark Timney President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Jan 2014
Pfizer Announces Top-Line Results From Two Phase 3 Trials Of Dacomitinib In Patients With Refractory Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Jan 2014
Synthetic Biologics Strengthens Clinical & Regulatory Team to Support Expanding Pipeline of Infectious Disease Programs
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 27 Jan 2014
Chelsea Therapeutics Announces Joseph G. Oliveto Named President and Chief Executive Officer, Director
Biopharmaceuticals Neurology Cardiology Personnel
 HSMN NewsFeed - 25 Jan 2014
Amorfix Announces Retirement of Walter von Wartburg
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jan 2014
PTC Therapeutics Expands Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jan 2014
Valeant Pharmaceuticals International, Inc. Completes Acquisition of Solta Medical, Inc.
Biopharmaceuticals Devices Mergers & Acquisitions
 HSMN NewsFeed - 24 Jan 2014
Theravance Appoints Frank Pasqualone Senior Vice President, Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jan 2014
Concert Pharmaceuticals Announces the Appointment of Ryan Daws as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jan 2014
Susan Kilsby to Succeed Matthew Emmens as Chairman of Shire
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jan 2014
Janssen Announces New Group Targeting Unmet Global Health Needs
Biopharmaceuticals
 HSMN NewsFeed - 21 Jan 2014
Keryx Biopharmaceuticals Announces Appointment of Daniel W. Olmstead as Vice President, Payer Access
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jan 2014
NuPathe Terminates Agreement With Endo and Enters Into Agreement to Be Acquired by Teva
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 20 Jan 2014
Aegerion Pharmaceuticals' JUXTAPID(R) (lomitapide) Capsules Approved in Mexico for the Treatment of Homozygous Familial Hypercholesterolemia (HoFH)
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 17 Jan 2014
European Commission Grants Marketing Authorization for Gilead’s Sovaldi(R) (Sofosbuvir) for the Treatment of Chronic Hepatitis C Infection
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 16 Jan 2014
CytRx Appoints Shanta Chawla, M.D. as Vice President, Clinical Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 16 Jan 2014
BioSyent Announces Appointment of New Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jan 2014
Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc.
Biopharmaceuticals Devices Mergers & Acquisitions
 HSMN NewsFeed - 15 Jan 2014
AbbVie Announces Initiation of Pivotal Phase 3 Study of Veliparib (ABT-888) for Patients with Early-Stage Triple-Negative Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Jan 2014
Antares Pharma Announces Availability of OTREXUP (Methotrexate) Injection for Subcutaneous Use to Treat Rheumatoid Arthritis (RA) and Psoriasis in Adults, and Polyarticular Idiopathic Arthritis (pJIA) in Children
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 14 Jan 2014
Osiris Therapeutics Board Confirms Lode Debrabandere, PhD, MBA, as President and Chief Executive Officer
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 14 Jan 2014
Actavis Appoints Industry Veterans to Lead U.S. Specialty Brands Business Units
Biopharmaceuticals Urology Gastroenterology Personnel
 HSMN NewsFeed - 14 Jan 2014
Ipsen to set up its own US oncology team for Somatuline(R) Depot(R) (lanreotide) Injection in neuroendocrine tumors
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Jan 2014
Ipsen and GW Pharmaceuticals plc Enter into Agreement for Ipsen to Promote and Distribute Sativex(R) in Latin America
Biopharmaceuticals Neurology Distribution
 HSMN NewsFeed - 13 Jan 2014
KemPharm Strengthens its Board of Directors as Company Prepares for Multiple Clinical and Business Milestones in 2014
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jan 2014
Seattle Genetics Appoints John A. Orwin to Board of Directors
Biopharmaceuticals Drug Delivery Oncology Personnel
 HSMN NewsFeed - 13 Jan 2014
OvaScience Provides Update on Pipeline Advancements and Commercial Plans; New Potential Fertility Treatment OvaPrime(SM) to Launch in 2015
Biopharmaceuticals
 HSMN NewsFeed - 13 Jan 2014
CorMedix Expands Neutrolin(R) Sales with Middle East Distribution Agreements
Biopharmaceuticals Devices Distribution
 HSMN NewsFeed - 13 Jan 2014
Merck Initiates Rolling Submission of U.S. Biologics License Application for MK-3475, an Investigational Anti-PD-1 Immunotherapy, in Patients with Advanced Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 13 Jan 2014
Arno Therapeutics Expands Management Team With Additions of Two Scientific Leaders
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Jan 2014
Jazz Pharmaceuticals Announces Acquisition From Aerial Biopharma Of Rights To A Late Stage Investigational Compound For Excessive Daytime Sleepiness
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 13 Jan 2014
Esperion Therapeutics Announces the Appointment of Antonio M. Gotto Jr., M.D., DPhil, as Director
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 13 Jan 2014
Mallinckrodt Pharmaceuticals and Medtronic Announce Clinical and Commercial Collaboration
Biopharmaceuticals Devices Drug Delivery Neurology
 HSMN NewsFeed - 13 Jan 2014
BioMarin Announces Selection of Factor VIII Gene Therapy Drug Development Candidate BMN 270 for the Treatment of Hemophilia A
Biopharmaceuticals
 HSMN NewsFeed - 13 Jan 2014
Alcobra Strengthens Management Team With Addition of Industry Veteran David C. Baker as Chief Commercial Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 13 Jan 2014
Portola Pharmaceuticals Enters Second Clinical Collaboration Agreement With Bristol-Myers Squibb and Pfizer to Study Andexanet Alfa* (PRT4445), Investigational Factor Xa Inhibitor Reversal Agent, With Eliquis
Biopharmaceuticals
 HSMN NewsFeed - 13 Jan 2014
Galena Biopharma Acquires Mills Pharmaceuticals, LLC
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 13 Jan 2014
Agenus Appoints Robert B. Stein, MD, PhD, as Chief Scientific Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Jan 2014
Agenus Enters into Definitive Agreement to Acquire Privately Held 4-Antibody AG
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 13 Jan 2014
Insys Announces Details of Product Development Pipeline
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 13 Jan 2014
Lilly Announces Acquisition of CGRP Antibody for Migraine Prevention from Arteaus Therapeutics
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 13 Jan 2014
U.S. FDA Approves Farxiga(TM) (Dapagliflozin) Tablets for the Treatment of Adult Patients with Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 13 Jan 2014
Incyte Names Hervé Hoppenot President and Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Jan 2014
A.P. Pharma Announces Appointment of New Directors and Effective Date of Name Change and Reverse Stock Split
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 13 Jan 2014
Genzyme and Alnylam Expand Collaboration on Rare Genetic Diseases
Biopharmaceuticals Licensing
 HSMN NewsFeed - 13 Jan 2014
Alnylam and Genzyme Form Transformational Alliance for RNAi Therapeutics as Genetic Medicines
Biopharmaceuticals Licensing
 HSMN NewsFeed - 10 Jan 2014
OvaScience Announces Global Healthcare Strategist Marc Kozin Joins Company’s Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jan 2014
Jonathan Barnsley Joins Ipsen as Executive Vice President, Technical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jan 2014
Akorn Acquires Betimol(R) from Santen
Biopharmaceuticals Ophthalmology Acquisitions
 HSMN NewsFeed - 9 Jan 2014
Sorrento Therapeutics Welcomes William S. Marth as Chairman of the Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 9 Jan 2014
Mallinckrodt Pharmaceuticals and Zogenix to End Co-Promotion Agreement
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 9 Jan 2014
OvaScience Appoints David Stern to Executive Vice President, Global Commercial Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jan 2014
Lion Biotechnologies Appoints James Bender, Ph.D., as Vice President, Product Development and Manufacturing
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 9 Jan 2014
Endo Announces Divestiture Of HealthTronics
Biopharmaceuticals Devices Mergers & Acquisitions
 HSMN NewsFeed - 9 Jan 2014
Biogen Idec and Sangamo BioSciences Announce Global Collaboration to Develop Treatments for Hemoglobinopathies
Biopharmaceuticals
 HSMN NewsFeed - 9 Jan 2014
Mylan Launches Generic Myfortic Delayed-Release Tablets
Biopharmaceuticals Generics FDA Product Launch
 HSMN NewsFeed - 9 Jan 2014
CytomX Therapeutics and ImmunoGen, Inc. Announce Strategic Collaboration to Develop Probody-Drug Conjugates Against Cancer Targets
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Jan 2014
Teva Names Erez Vigodman as President and CEO
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 8 Jan 2014
Vertex Announces Appointment of Jeffrey A. Chodakewitz, M.D., as Chief Medical Officer and Senior Vice President of Global Medicines Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jan 2014
Mylan Appoints Adele Gulfo as EVP, Global Collaboration and Strategic Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jan 2014
Ironwood Pharmaceuticals Announces Alignment of Workforce with Priority Growth Platforms
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 8 Jan 2014
Sorrento Therapeutics Appoints Amar Singh as Executive Vice President and Chief Business Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Jan 2014
Targacept Appoints John P. Richard as Chairman of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jan 2014
Merck Receives FDA Approval for ISENTRESS(R) (raltegravir) for Pediatric Oral Suspension
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 8 Jan 2014
Forest Laboratories to Acquire Aptalis for $2.9 Billion in Cash
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Jan 2014
BIND Therapeutics Announces Departure of Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Jan 2014
Lipocine Announces New Appointments to Its Board of Directors
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 7 Jan 2014
Mylan Launches Generic Detrol(R) LA Capsules
Biopharmaceuticals Generics Urology Product Launch
 HSMN NewsFeed - 7 Jan 2014
Dr. Seth Rudnick Joins G1 Therapeutics as Executive Chairman
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Jan 2014
Cortice Biosciences Announces the Appointment of George Farmer, Ph.D. as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Jan 2014
Allergan, Inc. and Medytox, Inc. Complete Licensing Agreement
Biopharmaceuticals Licensing
 HSMN NewsFeed - 7 Jan 2014
Forma Therapeutics Appoints Christopher Dinsmore to Vice President, Medicinal and Computational Chemistry
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2014
Impax and DURECT Sign a $63 Million Agreement to Develop and Commercialize DURECT’s ELADUR(R) Pain Patch
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 7 Jan 2014
KaloBios Appoints Harry Lam, Ph.D. as Head of Manufacturing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2014
Bellicum Pharmaceuticals Raises $34.4 Million in a Series B Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 7 Jan 2014
AMAG Pharmaceuticals Appoints Elizabeth Bolgiano as Senior Vice President of Human Resources
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2014
Cempra, Inc. Names David Moore as Chief Commercial Officer to Manage Commercial Development and Launch of Solithromycin and Taksta(TM)
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2014
Navidea Biopharmaceuticals Expands Lymphoseek(R) Global Commercialization Efforts
Biopharmaceuticals Radiology Distribution
 HSMN NewsFeed - 7 Jan 2014
Velocity Pharmaceutical Development Announces Appointment of Stuart Sedlack as Senior Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2014
Shield Therapeutics' ST10 Delivers Robust Results Meeting both Primary and Secondary Endpoints in the Pivotal AEGIS Phase 3 Programme for the Treatment of Iron Deficiency Anaemia in Inflammatory Bowel Disease
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 6 Jan 2014
Microbix Sues Novartis for Infringement of its VIRUSMAX(R) Patent
Biopharmaceuticals Litigation
 HSMN NewsFeed - 6 Jan 2014
Gilead Sciences’ Kevin Young CBE, Executive Vice President, Commercial Operations, to Retire
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jan 2014
Champions Oncology Names Angela Davies, M.D., Chief Medical Officer
Biopharmaceuticals Personalized Medicine Personnel
 HSMN NewsFeed - 6 Jan 2014
Tekmira Announces Strategic Reorganization to Strengthen Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jan 2014
Fibrocell Science Appoints Robert Sheroff, Vice President of Technical Operations
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 6 Jan 2014
ANI Pharmaceuticals Enters Development Agreement for Generic Drug Product with Sterling Pharmaceutical Services
Biopharmaceuticals Generics
 HSMN NewsFeed - 6 Jan 2014
Idenix Pharmaceuticals Appoints Jacques Dumas, Ph.D., as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jan 2014
Kala Pharmaceuticals Appoints Howard B. Rosen as Chairman of the Board of Directors
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 6 Jan 2014
Peregrine Pharmaceuticals Receives FDA Fast Track Designation for Its Immunotherapy Bavituximab as a Potential Treatment of Second-Line Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 6 Jan 2014
Soligenix Appoints Richard Straube, MD, as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jan 2014
PIXUVRI(R) (pixantrone) Receives Positive Final Appraisal Determination from NICE
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 3 Jan 2014
Iroko’s ZORVOLEX(TM) Now Available
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 3 Jan 2014
Teva Announces Launch of Authorized Generic of Detrol(R)
Biopharmaceuticals Generics Urology Product Launch
 HSMN NewsFeed - 3 Jan 2014
NPS Pharmaceuticals Receives Orphan Drug Designation for Natpara(R) in Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 3 Jan 2014
RegeneRx Receives Orphan Drug Designation for Tβ4 in the Treatment of Neurotrophic Keratopathy
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 3 Jan 2014
Aeterna Zentaris Appoints Dr. Richard Sachse as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jan 2014
Marina Biotech and Mirna Therapeutics Amend License Agreement for the Development of microRNA-Based Therapeutics
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 2 Jan 2014
Eisai Announces U.S. Availability of FYCOMPA(TM) (perampanel) CIII an Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy Age 12 and Older
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 2 Jan 2014
NeXeption, LLC Forms New Company Alexar Therapeutics, Inc. to Develop Novel LXR Agonist Portfolio for Dermatologic Indications; Raises $21.5 Million in Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 2 Jan 2014
Cell Therapeutics Announces Removal of the Partial Clinical Hold on Tosedostat
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 31 Dec 2013
Agilis Biotherapeutics Completes $8 Million Financing to Develop DNA-based Therapeutics for Rare Diseases
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 31 Dec 2013
George S. Zorich Named Chief Executive Officer of Agilis Biotherapeutics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Dec 2013
Star Scientific Receives a Warning Letter From the FDA Regarding Consumer Products
Biopharmaceuticals FDA
 HSMN NewsFeed - 31 Dec 2013
OphthaliX to Conduct a Retrospective Analysis of the Phase III Dry Eye Syndrome Study Data Based on the A3 Adenosine Receptor Biomarker
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 30 Dec 2013
Senesco Announces Letter of Intent to Merge with Fabrus
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 30 Dec 2013
Cubist Announces FDA Acceptance of Tedizolid New Drug Application with Priority Review
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Dec 2013
ImmunoGen, Inc. Appoints David Johnston as Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Dec 2013
Genzyme Receives Complete Response Letter from FDA on Lemtrada(TM) (alemtuzumab) Application
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 30 Dec 2013
FDA Approves SALMONELEX(TM) Against Salmonella as New Food Processing Aid
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Dec 2013
OphthaliX Announces Top-Line Results of Phase III Study with CF101 for Dry Eye Syndrome
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 30 Dec 2013
Concordia Healthcare Corp. announces filing of Ulesfia(R) with Health Canada
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 Dec 2013
European Medicines Agency (EMA) Accepts Otsuka's Marketing Authorisation Application (MAA) for Tolvaptan, an Investigational Compound for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 25 Dec 2013
Supernus Announces Resignation of Board Member
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 24 Dec 2013
Concordia Healthcare Corp. Announces Acquisition Of Pinnacle Biologics, Inc.
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 24 Dec 2013
AmpliPhi Biosciences Closes $18 Million Private Placement
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Dec 2013
European Commission Approves Update of Erbitux Metastatic Colorectal Cancer Labeling to Patients With RAS Wild-Type Tumors
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 23 Dec 2013
European Medicines Agency Accepts Marketing Authorization Application for The Medicines Company's Cangrelor
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 20 Dec 2013
Synta Announces Appointment of Steven Bernitz as Senior Vice President, Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Dec 2013
Cellceutix Files Orphan Drug Designation Application for Brilacidin for Oral Mucositis with US FDA
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 20 Dec 2013
Coronado Biosciences Announces Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Dec 2013
Takeda Announces Exclusive License and Option Agreement with Natrogen for Development of Natura-alpha for Inflammatory Bowel Disease
Biopharmaceuticals Gastroenterology Licensing
 HSMN NewsFeed - 19 Dec 2013
Vensun Pharmaceuticals, Inc. Completes Series B Financing
Biopharmaceuticals Generics Venture Capital
 HSMN NewsFeed - 19 Dec 2013
Baxter Receives FDA Approval of FEIBA [Anti-Inhibitor Coagulant Complex] for Prophylactic Treatment of Hemophilia A&B Patients with Inhibitors
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Dec 2013
Celator(R) Pharmaceuticals Appoints Joseph M. Lobacki to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Dec 2013
Genzyme’s Lemtrada(TM) Approved in Australia for Treatment of Multiple Sclerosis
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 19 Dec 2013
Bristol-Myers Squibb Continues Evolution to Specialty BioPharma Through Sale of Its Diabetes Business
Biopharmaceuticals Endocrinology Acquisitions
Older Biopharmaceutical stories   Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!